Dawn Rogers's most recent trade in DXC Technology Co was a trade of 12,300 Common Stock done . Disclosure was reported to the exchange on Aug. 13, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
DXC Technology Co | Dawn Rogers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 12,300 | 39,400 (0%) | 0% | 0 | Common Stock | |
DXC Technology Co | Dawn Rogers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2023 | 12,400 | 27,100 (0%) | 0% | 0 | Common Stock | |
DXC Technology Co | Dawn Rogers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2022 | 6,300 | 14,700 (0%) | 0% | 0 | Common Stock | |
DXC Technology Co | Dawn Rogers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Aug 2021 | 5,600 | 8,400 (0%) | 0% | 0 | Common Stock | |
DXC Technology Co | Dawn Rogers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2021 | 2,800 | 2,800 (0%) | 0% | 0 | Common Stock | |
Pfizer Inc. | Dawn Rogers | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2020 | 60 | 16,087 | - | - | Phantom Stock Units SSP | |
Pfizer Inc. | Dawn Rogers | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2020 | 52 | 15,996 | - | - | Phantom Stock Units SSP |